Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Effects of Motor Imagery and Action Observation on Upper Limb Motor Chances and Cognitive Chances in Parkinson's Disease

NCT05696925 · Federal University of Health Science of Porto Alegre · Updated 25 April 2025

What is being tested
Motor Imagery; Action Observation; Exoskeletons; Execution of the Action
For
Parkinson Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 20 years to 80 years. About 60 people. The full rules are on the registry page.
Where
Brazil
When
Starts or started 1 Feb 2023, ends 30 Nov 2024. Registered 25 Jan 2023.
Results
None posted yet.

In the researchers' words

Parkinson's disease is degenerative, progressive, and chronic. It is considered potentially disabling, in view of the motor alterations, such as bradykinesia, rigidity, and tremor in the upper limbs, and non-motor alterations, such as cognitive ones involving attention, concentration and memory difficulties. Thus, neurorehabilitation modalities, such as motor imagery and action observation, have been used. The aim of this research is to investigate the effects of motor imagery and action observation on upper limb motor and cognitive changes in Parkinson's disease. This is a randomized controlled trial type study. The population of the study involves people with Parkinson's disease in stages 1-3 on the Hoehn and Yahr scale, aged 20 to 80 years, who must be on stable medication, have no cognitive impairment with risk of dementia, be able to imagine motor activities and have upper limb motor impairment. The study groups will be: a) motor imagery, observation of action and motor execution; b) motor imagery and motor execution; c) observation of action and motor execution; d) motor imagery and motor execution and exoskeleton; e) observation of action and motor execution and exoskeleton. The interventions of all groups will be an intensive approach of 10 continuous sessions, with a two-day break in the middle of the intervention, totaling two weeks, with each session lasting 40…
ClinicalTrials.gov, NCT05696925

Sites

  • UFCSPAPorto Alegre, Brazil